Founded in 1998, ESBATech is a privately owned spin-off biotechnology company that originated from the University of Zurich, Switzerland. ESBATech is focused on developing its therapeutic applications of its proprietary fully human antibody fragments. The company is aiming to become one of the leading companies in human antibody fragments for therapeutic applications.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
All rights reserved. Terms and Conditions | Contact us
